| 1 | Chemosensitization of Temozolomide-Resistant Pediatric Diffuse Midline Glioma Using Potent Nanoencapsulated Forms of a N(3)-Propargyl Analogue. 2021;13:35266 doi: 10.1021/acsami.1c04164 |
| 2 | Dynamics of Ring-Cleavage Reactions in Temozolomide Induced by Low-Energy Electron Attachment. 2022;10: doi: 10.3389/fphy.2022.880689 |
| 3 | Delivery of Temozolomide and N3-Propargyl Analog to Brain Tumors Using an Apoferritin Nanocage. 2020;12:12609 doi: 10.1021/acsami.0c01514 |
| 4 | Combinatory Treatment with miR-7-5p and Drug-Loaded Cubosomes Effectively Impairs Cancer Cells. 2020;21:5039 doi: 10.3390/ijms21145039 |
| 5 | Novel Imidazotetrazine Evades Known Resistance Mechanisms and Is Effective against Temozolomide-Resistant Brain Cancer in Cell Culture. 2022;17:299 doi: 10.1021/acschembio.2c00022 |
Cancer Drug Resistance
